ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Beryl Drugs Ltd submitted a certificate claiming exemption from Corporate Governance provisions under Regulation 15(2) of SEBI LODR for the year ended March 31, 2026. The company qualifies for the exemption as its paid-up capital (₹5.07 Crore) and net worth (₹9.50 Crore) remain below the prescribed regulatory thresholds.
Beryl Drugs Ltd has submitted its quarterly compliance reports for the period ended March 31, 2026. The filing includes certificates regarding dematerialisation of securities and maintenance of share transfer facilities. These are routine regulatory submissions ensuring administrative and operational transparency for shareholders.
Beryl Drugs Ltd submitted compliance certificates for the quarter and year ended March 31, 2026. The filings confirm maintenance of share transfer facilities by Adroit Corporate Services and compliance with SEBI depository and non-applicability regulations.